{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1040287907231159808.json","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21H02951"},{"@type":"JGN","@value":"JP21H02951"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21H02951/"}],"jpcoar:awardTitle":[{"@language":"ja","@value":"治療後微小残存する白血病幹細胞に対する新規治療標的の開発"},{"@language":"en","@value":"Targeting minimal residual leukemic stem cells"}],"field":[{"keyword":[{"language":"ja","textList":["小区分54010:血液および腫瘍内科学関連"]},{"language":"en","textList":["Basic Section 54010:Hematology and medical oncology-related"]}]}],"dc:language":"ja","description":[{"type":"outline_of_research_initial","notation":[{"@language":"ja","@value":"本研究ではTIM-3シグナル阻害療法の開発を見据えて、TIM-3でマークされる治療後に残存する治療抵抗性白血病幹細胞(LSCs)の細胞生物学的特性の解明に取り組む。治療後に残存する極少数のLSCsを直接純化し、genomic解析技術、single cell transcriptome解析により、治療抵抗性残存LSCsの多様性の解明を行う。さらに質量分析装置をベースとした網羅的シグナル解析を行い、治療抵抗性LSCsが依存するシグナル経路の解明に取り組む。これら研究により治療後に残存するTIM-3陽性治療抵抗性LSCsを根絶するための基盤とする。"}]}],"researcher":[{"@id":"https://cir.nii.ac.jp/crid/1420282801208669184","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"40619706"},{"@type":"NRID","@value":"1000040619706"},{"@type":"NRID","@value":"9000323295745"},{"@type":"NRID","@value":"9000242371485"},{"@type":"NRID","@value":"9000391518821"},{"@type":"NRID","@value":"9000258045283"},{"@type":"NRID","@value":"9000021259595"},{"@type":"NRID","@value":"9000257904662"},{"@type":"NRID","@value":"9000018877369"},{"@type":"NRID","@value":"9000251861239"},{"@type":"NRID","@value":"9000403273655"},{"@type":"NRID","@value":"9000411023013"},{"@type":"NRID","@value":"9000382236273"},{"@type":"NRID","@value":"9000397648362"},{"@type":"NRID","@value":"9000337089741"},{"@type":"NRID","@value":"9000356621916"},{"@type":"NRID","@value":"9000258044790"},{"@type":"NRID","@value":"9000290814027"},{"@type":"NRID","@value":"9000388448664"},{"@type":"NRID","@value":"9000015286245"},{"@type":"NRID","@value":"9000314071120"},{"@type":"NRID","@value":"9000367850080"},{"@type":"NRID","@value":"9000367850057"}],"foaf:name":[{"@language":"ja","@value":"菊繁 吉謙"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学"}],"role":"co_investigator_buntan"},{"@id":"https://cir.nii.ac.jp/crid/1420564276166068992","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"70343324"},{"@type":"NRID","@value":"1000070343324"},{"@type":"NRID","@value":"9000021160819"},{"@type":"NRID","@value":"9000240189477"},{"@type":"NRID","@value":"9000326654308"},{"@type":"NRID","@value":"9000279913615"},{"@type":"NRID","@value":"9000317164675"},{"@type":"NRID","@value":"9000021930828"},{"@type":"NRID","@value":"9000363335878"},{"@type":"NRID","@value":"9000257905049"},{"@type":"NRID","@value":"9000021259622"},{"@type":"NRID","@value":"9000020887370"},{"@type":"NRID","@value":"9000366514885"},{"@type":"NRID","@value":"9000317563986"},{"@type":"NRID","@value":"9000257904657"},{"@type":"NRID","@value":"9000344833441"},{"@type":"NRID","@value":"9000240540632"},{"@type":"NRID","@value":"9000397827879"},{"@type":"NRID","@value":"9000010597680"},{"@type":"NRID","@value":"9000376556013"},{"@type":"NRID","@value":"9000020805832"},{"@type":"NRID","@value":"9000398776225"},{"@type":"NRID","@value":"9000240037870"},{"@type":"NRID","@value":"9000240055743"},{"@type":"NRID","@value":"9000259835382"},{"@type":"NRID","@value":"9000379560790"},{"@type":"NRID","@value":"9000326666938"},{"@type":"NRID","@value":"9000020486777"},{"@type":"NRID","@value":"9000310002242"},{"@type":"NRID","@value":"9000240037668"},{"@type":"NRID","@value":"9000258014585"},{"@type":"NRID","@value":"9000282416361"},{"@type":"NRID","@value":"9000258036091"},{"@type":"NRID","@value":"9000397648262"},{"@type":"NRID","@value":"9000403266202"}],"foaf:name":[{"@language":"ja","@value":"宮本 敏浩"},{"@language":"en","@value":"Miyamoto Toshihiro"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"金沢大学"}],"role":"principal_investigator"}],"since":"2021-04-01","until":"2024-03-31","institution":[{"institutionIdentifier":[{"@type":"NII","@value":"0013301"}],"notation":[{"@language":"ja","@value":"金沢大学"},{"@language":"en","@value":"Kanazawa University"}]}],"fundingProgram":[{"jpcoar:funderName":[{"@language":"ja","@value":"科学研究費助成事業"},{"@language":"en","@value":"Grants-in-Aid for Scientific Research"}]}],"url":[{"@id":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21H02951/","notation":[{"@value":"KAKEN"}]}],"createdAt":"2021-04-28","modifiedAt":"2025-11-20","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=%E6%80%A5%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85","dc:title":"急性白血病"},{"@id":"https://cir.nii.ac.jp/all?q=%E7%99%BD%E8%A1%80%E7%97%85%E5%B9%B9%E7%B4%B0%E8%83%9E","dc:title":"白血病幹細胞"},{"@id":"https://cir.nii.ac.jp/all?q=%E5%BE%AE%E5%B0%8F%E6%AE%8B%E5%AD%98%E7%97%85%E5%A4%89","dc:title":"微小残存病変"},{"@id":"https://cir.nii.ac.jp/all?q=%E6%B2%BB%E7%99%82%E6%8A%B5%E6%8A%97%E6%80%A7","dc:title":"治療抵抗性"},{"@id":"https://cir.nii.ac.jp/all?q=TIM-3","dc:title":"TIM-3"}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360298754846043136","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1182/bloodadvances.2022008242"},{"@type":"URI","@value":"https://ashpublications.org/bloodadvances/article-pdf/7/14/3592/2065310/blooda_adv-2022-008242-main.pdf"},{"@type":"PMID","@value":"36044390"}],"notation":[{"@value":"Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580230630406400","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.rpth.2023.100076"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S2475037923000432?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S2475037923000432?httpAccept=text/plain"},{"@type":"PMID","@value":"36861115"}],"notation":[{"@value":"Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579820396419456","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1182/bloodadvances.2022008405"},{"@type":"URI","@value":"https://ashpublications.org/bloodadvances/article-pdf/7/10/2053/2052444/blooda_adv-2022-008405-main.pdf"},{"@type":"PMID","@value":"36745103"}],"notation":[{"@value":"TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865815493725824","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1002/ajh.26769"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26769"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ajh.26769"},{"@type":"PMID","@value":"36260658"}],"notation":[{"@value":"Predictors of impaired antibody response after <scp>SARS‐CoV</scp>‐2 <scp>mRNA</scp> vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341826745984","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/ejh.13972"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13972"}],"notation":[{"@value":"<scp><i>IKZF1</i><sup><i>plus</i></sup></scp> alterations are not associated with outcomes in Philadelphia‐positive acute lymphoblastic leukemia patients enrolled in the <scp>FBMTG ALL</scp>/<scp>MRD2008</scp> trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865815501523840","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/cas.15835"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15835"},{"@type":"PMID","@value":"37197765"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2024302842"}],"notation":[{"@value":"<scp>GPAM</scp> mediated lysophosphatidic acid synthesis regulates mitochondrial dynamics in acute myeloid leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341822955136","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.vaccine.2023.08.066"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0264410X23010228?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0264410X23010228?httpAccept=text/plain"},{"@type":"PMID","@value":"37866994"}],"notation":[{"@value":"Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584341823852416","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1038/s41467-023-42718-0"},{"@type":"URI","@value":"https://www.nature.com/articles/s41467-023-42718-0.pdf"},{"@type":"URI","@value":"https://www.nature.com/articles/s41467-023-42718-0"},{"@type":"PMID","@value":"37907518"}],"notation":[{"@value":"Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1020584168862036097","@type":"Book","resourceType":"図書(book)","notation":[{"@language":"ja","@value":"血液症候群・後天性再生不良性貧血"}]},{"@id":"https://cir.nii.ac.jp/crid/1020584168862036096","@type":"Book","resourceType":"図書(book)","notation":[{"@language":"ja","@value":"血液症候群・再生不良性貧血-発作性夜間ヘモグロビン尿症症候群"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943386136832","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s12185-021-03239-y"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s12185-021-03239-y.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s12185-021-03239-y/fulltext.html"},{"@type":"PMID","@value":"34773575"}],"notation":[{"@value":"Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142673764480","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1038/s41409-020-01082-z"},{"@type":"URI","@value":"http://www.nature.com/articles/s41409-020-01082-z.pdf"},{"@type":"URI","@value":"http://www.nature.com/articles/s41409-020-01082-z"},{"@type":"PMID","@value":"33139867"}],"notation":[{"@value":"Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282463424896","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1080/10428194.2021.2002321"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.2002321"}],"notation":[{"@value":"Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy\n            <sup>*</sup>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643814097408","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s00277-020-04310-0"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s00277-020-04310-0.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s00277-020-04310-0/fulltext.html"},{"@type":"PMID","@value":"33150464"}],"notation":[{"@value":"Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617516355584","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1182/bloodadvances.2020003639"},{"@type":"URI","@value":"http://ashpublications.org/bloodadvances/article-pdf/5/2/475/1797883/advancesadv2020003639.pdf"},{"@type":"PMID","@value":"33496743"}],"notation":[{"@value":"Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282455505024","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s12185-022-03414-9"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s12185-022-03414-9.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s12185-022-03414-9/fulltext.html"},{"@type":"DOI","@value":"10.21203/rs.3.rs-957642/v1"},{"@type":"PMID","@value":"35821550"}],"notation":[{"@value":"ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282465520128","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/cas.15458"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15458"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cas.15458"},{"@type":"PMID","@value":"35689544"}],"notation":[{"@value":"Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118743432064","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1182/bloodadvances.2021004618"},{"@type":"URI","@value":"https://ashpublications.org/bloodadvances/article-pdf/6/7/2388/1887501/advancesadv2021004618.pdf"},{"@type":"PMID","@value":"34638128"}],"notation":[{"@value":"A germinal center–associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298754843077504","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1080/10428194.2021.1941937"},{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1941937"},{"@type":"PMID","@value":"34159882"}],"notation":[{"@value":"Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643787034240","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1038/s41409-021-01485-6"},{"@type":"URI","@value":"https://www.nature.com/articles/s41409-021-01485-6.pdf"},{"@type":"URI","@value":"https://www.nature.com/articles/s41409-021-01485-6"},{"@type":"PMID","@value":"34625663"}],"notation":[{"@value":"Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282455494272","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s12185-021-03116-8"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s12185-021-03116-8.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s12185-021-03116-8/fulltext.html"},{"@type":"PMID","@value":"33725318"}],"notation":[{"@value":"Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008"}]}],"dataSourceIdentifier":[{"@type":"KAKEN","@value":"21H02951"}],"grant":{"grantIdentifier":[{"@type":"NII","@value":"69"}],"jpcoar:fundingStream":[{"@language":"ja","@value":"基盤研究(B)"},{"@language":"en","@value":"Grant-in-Aid for Scientific Research (B)"}]},"allocationClassification":[{"notation":[{"@language":"ja","@value":"補助金"},{"@language":"en","@value":"Single-year Grants"}]}],"projectStatus":"project_closed","allocationAmount":{"totalCost":{"amount":"17550000","currency":"JPY"},"breakdownCost":[{"notation":[{"@language":"ja","@value":"直接経費"},{"@language":"en","@value":"Direct Cost"}],"amount":"13500000","currency":"JPY"},{"notation":[{"@language":"ja","@value":"間接経費"},{"@language":"en","@value":"Indirect Cost"}],"amount":"4050000","currency":"JPY"}]}}